Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Munich - Delayed Quote • EUR InspireMD Inc (II2.MU) Follow Add holdings 2.2800 0.0000 (0.00%) As of 8:01:06 AM GMT+2. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for II2.MU 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: II2.MU View More All News Press Releases SEC Filings InspireMD to Announce First Quarter 2025 Financial Results InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference InspireMD Full Year 2024 Earnings: US$0.76 loss per share (vs US$0.82 loss in FY 2023) InspireMD Inc (NSPR) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Rising Expenses and ... InspireMD Reports Fourth Quarter and Full Year 2024 Financial Results InspireMD to Announce Fourth Quarter and Full Year 2024 Financial Results Investors in InspireMD (NASDAQ:NSPR) have unfortunately lost 78% over the last five years InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal Clinical Trial of the CGuard Prime™ 80 cm Carotid Stent System for Use in TCAR procedures Here's Why We're Watching InspireMD's (NASDAQ:NSPR) Cash Burn Situation InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025